Understanding and reducing monkeypox and other zoonotic diseases in the Democratic Republic of the Congo.
Official title: RFA-CK-22-001, Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) - 2022
Funded at Kinshasa School of Public Health · NIH-10846542 · Data updated 2026-11-12
This study is all about learning more about monkeypox and similar diseases in the Democratic Republic of the Congo, so we can better help people affected by them; it includes training health workers, improving testing methods, and finding out how these diseases spread, all while working closely with local communities.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kinshasa School of Public Health NIH-funded |
| Lab location | 1 site (Kinshasa, Congo Dem Rep) |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2024 |
| Award (this year) | $450,000 |
| NIH project number | 5U01CK000666-03 |
| Project ID | NIH-10846542 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals living in or near areas affected by monkeypox and other zoonotic diseases in the DRC.
✕Less likely to help
Patients living outside the Democratic Republic of the Congo or those not affected by zoonotic diseases may not receive any benefit from this research.
What this research studies
This research aims to enhance the understanding of monkeypox and other zoonotic diseases in the Democratic Republic of the Congo (DRC) while reducing their clinical impact. The project will establish a laboratory-based surveillance system to gather accurate data on disease burden and will involve training health workers, improving geographic data, and assessing new diagnostic methods. Clinical trials will be conducted to evaluate care regimens, vaccines, and antiviral therapies, alongside serosurveys to understand transmission risks and viral persistence. The research will also focus on identifying wildlife reservoirs and gathering insights from affected communities to improve outbreak response.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for monkeypox and other zoonotic diseases, ultimately improving public health in the DRC.
How similar studies have gone: Previous research has shown success in improving public health responses to zoonotic diseases through similar surveillance and training approaches.
Where this research is happening
-
Kinshasa School of Public Health
Kinshasa, Congo Dem Rep Active
Researchers
- Principal investigator: Kaba, Didine Kinkodi — Kinshasa School of Public Health
- Study coordinator: Kaba, Didine Kinkodi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.